We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wockhardt Gets another FDA Warning Letter over GMP Deficiencies
Wockhardt Gets another FDA Warning Letter over GMP Deficiencies
CP Pharmaceuticals, a subsidiary of drug manufacturer Wockhardt Limited, received a warning letter that inspection of its facility revealed significant GMP violations.